The largest database of trusted experimental protocols

Firefly luciferase

Manufactured by Thermo Fisher Scientific

Firefly luciferase is a bioluminescent enzyme extracted from the firefly. It catalyzes the oxidation of luciferin, a substrate, resulting in the emission of light. The core function of firefly luciferase is to serve as a reporter or marker in various biological and biochemical applications.

Automatically generated - may contain errors

6 protocols using firefly luciferase

1

Intravascular ATP Release Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Optical imaging of luciferin-luciferase activity was performed to temporally and spatially assess intravascular ATP release. Mice were injected intraperitoneally with 3 mg D-luciferin (Thermo Fisher, Waltham, Massachusetts) by intraperitoneal route immediately before therapeutic US with MB cavitation. Firefly luciferase (25 μg, Thermo Fisher) was injected by intravenous route 1 min prior to completion of the 10 min US exposure. Optical imaging (IVIS Spectrum, Caliper Life Sciences Hopkinton, Massachusetts) was performed at 5, 10, 15, and 20 min after completion of US using medium binning. Data were expressed as photons/s/cm2.
+ Open protocol
+ Expand
2

Quantification of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blots were performed using antibodies against NFAT1(Cell
Signalling, 5861S), pS6K(T389) (Cell Signaling, 9234S), pCamKII(T286) (Cell
Signalling, 12716S), MeCP2 (Cell Signalling, 3456S), pMeCP2(S421)(Rockland,
600-401-X14), Firefly luciferase (Thermo, PA5-32209). The Electrophoresis
and Membrane-Transfer were performed by iBlot (Invitrogen). Imaging was
obtained by Odyssey (Li-Cor) system, following the manufacturer’s
protocol.
+ Open protocol
+ Expand
3

Immunofluorescent Microscopy of Mouse Brain and Pancreas

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thin sections (5–10 µm) from mouse brain or pancreas were obtained and analyzed by immunofluorescent microscopy, as described previously (26 (link)). Every fifth section was analyzed with anti–β-galactosidase (β-gal) for the PRV-BaBlu map. PRV-Ba2001 was analyzed by anti-green fluorescent protein (GFP). Stereotaxic injections were verified by anti-fLuc or anti-HKI. Secondary antibodies were from Jackson ImmunoResearch (West Grove, PA). The primary antibodies used were as follows: β-gal and GFP (Abcam, Cambridge, MA); Cre-recombinase (Novagen/Millipore, Billerica, MA); insulin (Linco/Millipore, Billerica, MA); glucokinase (GK) (Santa Cruz Biotechnology, Dallas, TX); firefly luciferase (Thermo Fisher Scientific, Bannockburn, IL), and hexokinase-1 (HK1) (Cell Signaling, Danvers, MA). For all primary antibodies, immunofluorescent analysis with controls was conducted on adjacent brain sections for autofluorescence, secondary antibody alone, and nonimmune antibody preparations for the appropriate species. Anatomical brain areas were defined by the atlas of Franklin and Paxinos (27 ) using DAPI-positive nuclei and hematoxylin-eosin staining from adjacent sections. An average of at least 140 brain sections/animal were assessed from four or more animals.
+ Open protocol
+ Expand
4

Optical Imaging of Muscle ATP Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
In 6 mice, optical imaging with a luciferin-luciferase activity was performed to quantify regional ATP production after catheter-based US exposure of the proximal hindlimb muscles (Belcik, et al. 2017 (link)). Mice were injected with 3 mg D-luciferin (Thermo Fisher, Waltham, MA) by intraperitoneal route immediately before US; and firefly luciferase (5 μg, Thermo Fisher) was injected by IV route 1 min prior to completion of US exposure. Optical imaging (IVIS Spectrum, Caliper Life Sciences) was performed 5 minutes after completion of US using medium binning and data were expressed as photons/s/cm2. Release of ATP from erythrocytes, which has been described during high power US cavitation of microbubbles (Belcik, et al. 2017 (link)), was also assessed. Dialysis cassettes (Thermo Fisher) were filled with 3 mL of heparinized blood from normal human volunteers. Cassettes were exposed to US by positioning the EkoSonic catheter adjacent to the membrane using US coupling gel. A total of 4 experiments were averaged and, for each, a control experiment without US was performed. After 5 minutes of US, optical imaging was performed immediately after adding luciferase (10 μg) and D-luciferin (1.2 mg) to each cassette.
+ Open protocol
+ Expand
5

Intravascular ATP Release Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Optical imaging of luciferin-luciferase activity was performed to temporally and spatially assess intravascular ATP release. Mice were injected IP with 3 mg D-luciferin (Thermo Fisher, Waltham, MA) by IP route immediately before therapeutic US with MB cavitation. Firefly luciferase (25 μg, Thermo Fisher) was injected by IV route 1 min prior to completion of the 10 min US exposure. Optical imaging (IVIS Spectrum, Caliper Life Sciences) was performed at 5, 10, 15, and 20 min after completion of US using medium binning. Repeat injections of D-luciferin and luciferase were repeated 24 hrs later. Data were expressed as photons/s/cm2.
+ Open protocol
+ Expand
6

Bioluminescent ATP Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Homogenized tissue was lysed in a lysis buffer (Promega Dual Luciferase Assay Kit) and briefly centrifuged to assess ATP content in target tissues. The supernatant was mixed with a reaction mix containing Firefly Luciferase and Luciferin (Thermo Scientific). The measured luminescence is a direct result of the presence of free ATP, which fuels the conversion of Luciferin to OxyLuciferin by the Luciferase. Luminescence was determined in the Promega GlowMAX.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!